EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 -0.8057
March 31, 2026 -0.8839
December 31, 2025 -0.9198
September 30, 2025 -0.9257
June 30, 2025 -0.8922
March 31, 2025 -0.8449
December 31, 2024 -0.8299
September 30, 2024 -0.9383
June 30, 2024 -0.969
March 31, 2024 -1.090
December 31, 2023 -1.341
September 30, 2023 -1.863
June 30, 2023 -2.031
March 31, 2023 -2.607
December 31, 2022 -2.773
September 30, 2022 -2.354
June 30, 2022 -2.303
March 31, 2022 -1.822
December 31, 2021 -1.698
September 30, 2021 -1.555
June 30, 2021 -1.472
March 31, 2021 -1.359
December 31, 2020 -1.321
Date Value
September 30, 2020 -1.320
June 30, 2020 -12.27
March 31, 2020 -12.41
December 31, 2019 -12.37
September 30, 2019 -12.45
June 30, 2019 -1.536
March 31, 2019 -1.493
December 31, 2018 -1.536
September 30, 2018 -1.453
June 30, 2018 -1.422
March 31, 2018 -1.920
December 31, 2015 -1.815
September 30, 2015 -1.814
June 30, 2015 -1.918
March 31, 2015 -1.426
December 31, 2014 -1.428
September 30, 2014 -1.961
June 30, 2014 -1.777
March 31, 2014 -1.650
December 31, 2013 -1.553
September 30, 2013 -0.7577
June 30, 2013 -0.4934
March 31, 2013 -0.2432

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Myriad Genetics, Inc. -1.199
BioRestorative Therapies, Inc. -22.40
CareDx, Inc. 2.075
Natera, Inc. -1.368
Sera Prognostics, Inc. -0.6636